108938-16-5

Basic information

• Product Name: 7-BROMO-5-METHYL-1H-INDOLE-2,3-DIONE
• Synonyms: BUTTPARK 50\07-85;CHEMBRDG-BB 4010945;7-BROMO-5-METHYL-1H-INDOLE-2,3-DIONE;7-BROMO-5-METHYLINDOLINE-2,3-DIONE;AKOS BBS-00001014;7-bromo-5-methyl-1H-indole-2,3-dione(SALTDATA: FREE);1H-Indole-2,3-dione, 7-broMo-5-Methyl-;7-broMo-5-Methyl-2,3-dihydro-1H-indole-2,3-dione
• CAS NO: 108938-16-5
• Molecular Formula: C₉H₆BrNO₂
• Molecular Weight: 240.05
• Product Categories: Indoline & Oxindole
• Mol File: 108938-16-5.mol

Chemical Properties

• Melting Point: 176-180 °C
• Appearance: /
• Density: 1.714 g/cm³
• Refractive Index: 1.631
• PKA: 8.70±0.20(Predicted)
• CAS DataBase Reference: 7-BROMO-5-METHYL-1H-INDOLE-2,3-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-BROMO-5-METHYL-1H-INDOLE-2,3-DIONE(108938-16-5)
• EPA Substance Registry System: 7-BROMO-5-METHYL-1H-INDOLE-2,3-DIONE(108938-16-5)

Safety Data

• Hazardous Substances Data: 108938-16-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
7-BROMO-5-METHYL-1H-INDOLE-2,3-DIONE is used as a chemical intermediate for the development of pharmaceutical drugs due to its diverse biological activities and potential medicinal applications. Its unique structure with a bromine atom and a methyl group may contribute to its specific properties, making it a promising candidate for further research and drug development.

InChI:InChI=1/C9H6BrNO2/c1-4-2-5-7(6(10)3-4)11-9(13)8(5)12/h2-3H,1H3,(H,11,12,13)

Upstream product

• 608-05-9 5-methyl-indole-2,3-dione 
• 106-49-0 p-toluidine 
• 1132-40-7 2-hydroxyimino-N-p-tolyl-acetamide 
• 583-68-6 2-bromo-p-toluidine 
• 124807-88-1 2-bromo-4-methyl-α-isonitrosoacetanilide 

Downstream Products

• 124807-89-2 7-bromo-1,5-dimethylindoline-2,3-dione 
• 206551-32-8 methyl 2-amino-3-bromo-5-methyl benzoate 
• 893651-25-7 C₁₉H₁₈BrN₃O₅ 
• 13091-43-5 2-amino-3-bromo-5-methylbenzoic acid 

Relevant articles and documents

Bicyclic heteroaryl compound with PAR4 antagonistic activity and application thereof

The invention discloses a bicyclic heteroaryl compound with PAR4 antagonistic activity and application thereof. The invention provides the bicyclic heteroaryl compound with PAR4 antagonistic activity,and the bicyclic heteroaryl compound has remarkable antagonistic activity on PAR4 in an in-vitro anti-platelet aggregation experiment, so that platelet aggregation is effectively inhibited, and the bicyclic heteroaryl compound can be used for preparing medicines for preventing or treating various thromboembolic diseases.

Synthesis of 3,4-Dihydro-1,4-ethenonaphthalen-2(1H)-ones by Benzyne Cycloadditions.

As part of a project on the photochemistry of 3,4-dihydro-1,4-ethanonaphthalen-2(1H)-ones (benzobicyclooctanones), we were interested in preparing the model 9-ene precursors shown in Scheme 1.On the basis of previous work, it was envisaged that the

Synthesis of some Newer Biologically Active Substituted-3-((6-substituted-2-hydrazono)benzothiazolyl)-2-indolines. Part LIV

5-Bromo- and 5-methyl-7-bromoisatins (1a) have been synthesised and transformed into the corresponding 1-methyl analogs (1b). 1a and 1b have been condensed with 2-hydrazinobenzothiazoles to yield 3 and 4.Mannich condensation of 3 using morpholine and piperidine furnished the corresponding 1-morpholino/piperidinomethyl analogs (5).The compounds have been characterised by means of ir and pmr spectroscopy.

Isatin compositions having anti-ulcer activities

This invention provides novel isatin compounds which are useful as therapeutic agents. The invention isatin compounds and the pharmaceutically acceptable salts thereof exhibit anti-ulcer activities which are applicable for propylaxis and treatment of ulcer diseases in the digestive tract of animals.